INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.400
-0.070 (-4.76%)
At close: Apr 28, 2026, 4:00 PM EDT
1.426
+0.026 (1.86%)
After-hours: Apr 28, 2026, 6:49 PM EDT
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $37.22 million as of April 28, 2026. Its market cap has decreased by -78.01% in one year.
Market Cap
37.22M
Enterprise Value
13.90M
1-Year Change
-78.01%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $37.22M, a decrease of -52.18%. That is a compound annual growth rate of -9.70%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinium Pharmaceuticals | 39.91M |
| Aligos Therapeutics | 39.60M |
| Werewolf Therapeutics | 39.51M |
| RenovoRx | 38.59M |
| NextCure | 37.46M |
| Veru Inc. | 37.24M |
| CervoMed | 35.92M |
| Grace Therapeutics | 35.59M |